Source:http://linkedlifedata.com/resource/pubmed/id/17608733
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2008-2-8
|
pubmed:abstractText |
E-cadherin expression is unusually regulated in epithelial ovarian carcinoma. It is not expressed in poorly cohesive ovarian surface epithelial (OSE) target cells, but is expressed in cohesive pre-malignant lesions and in highly cohesive, well-differentiated tumors where it is membrane associated, presumably in adherens junctions. E-cadherin expression is subsequently suppressed, or its function is disrupted, in late-stage invasive tumors. Here, we observed that increased E-cadherin expression in ovarian carcinoma cells was associated with increased E-cadherin promoter activity, increased adherens junction formation, decreased beta-catenin signaling-dependent LEF-1 activity, and the generation of cohesive spheroids in basement membrane gel culture. Forced expression of wild-type E-cadherin in immortalized OSE cells initiated adherens junction formation, decreased LEF-1 activity, decreased the mesenchymal migration that is a characteristic of OSE cells that have been maintained in monolayer culture, and induced the formation of cohesive spheroids in basement membrane gels. Conversely, forced expression of a dominant-negative E-cadherin mutant in ovarian carcinoma cells disrupted adherens junctions, increased mesenchymal cell migration, and prevented spheroidal morphogenesis without altering LEF-1 signaling. Therefore, in addition to suppressing late-stage tumor progression, E-cadherin-mediated adherens junctions may also contribute to the initial emergence of a cohesive morphogenic phenotype that is a hallmark of differentiated epithelial ovarian carcinoma.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1432-0436
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
76
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
193-205
|
pubmed:meshHeading |
pubmed-meshheading:17608733-Adherens Junctions,
pubmed-meshheading:17608733-Cadherins,
pubmed-meshheading:17608733-Carcinoma,
pubmed-meshheading:17608733-Cell Line, Tumor,
pubmed-meshheading:17608733-Cell Proliferation,
pubmed-meshheading:17608733-Epithelial Cells,
pubmed-meshheading:17608733-Female,
pubmed-meshheading:17608733-Humans,
pubmed-meshheading:17608733-Lymphoid Enhancer-Binding Factor 1,
pubmed-meshheading:17608733-Ovarian Neoplasms
|
pubmed:year |
2008
|
pubmed:articleTitle |
The morphogenic function of E-cadherin-mediated adherens junctions in epithelial ovarian carcinoma formation and progression.
|
pubmed:affiliation |
Department of Cellular and Physiological Sciences, Life Science Center University of British Columbia, Vancouver, BC, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|